On Thursday, MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) announced the formulation of Ketamir-2 as a topical treatment for localized neuropathic and inflammatory pain. The advancement expands the ...
Quoin Pharmaceuticals Ltd. has announced the filing of U.S. and International patent applications for new topical formulations of rapamycin aimed at treating rare diseases such as microcystic ...
BOSTON--(BUSINESS WIRE)--DermBiont, a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced today that it has raised a ...
FAIRFAX, Va.--(BUSINESS WIRE)--Vizuri Health Sciences LLC, a pharmaceutical and over-the-counter (OTC) product development company, today announced the issuance of a U.S. patent that further protects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results